MMS · NYSE · Specialty Business Services

Maximus (MMS)

Runs tech-enabled health, human-services, clinical, and technology programs for governments.

$55.18
After hours−0.08 (−0.14%)
At close$55.26(−1.27%)

In millions of USD, except per-share figures

In millionsQ4 FY23Sep 2023Q1 FY24Dec 2023Q2 FY24Mar 2024Q3 FY24Jun 2024Q4 FY24Sep 2024Q1 FY25Dec 2024Q2 FY25Mar 2025Q3 FY25Jun 2025Q4 FY25Sep 2025Q1 FY26Dec 2025Q2 FY26Mar 2026Q3 FY26Jun 2026
Revenue1,2601,3271,3481,3151,3161,4031,3621,3481,3181,3451,3061,279
Cost of revenue9931,0501,0521,0061,0371,1241,0461,0121,0081,047984930
Gross profit267277296309279279316337311298322349
170167168167166153163171187161173187
Selling, general & administrative1701671681671661531631711871521730
Other expenses00000000090187
Operating income97109128142113125153166124137148161
−18−24−20−22−20−56−21−23−23−11−22−23
Interest expense212220212018212322192424
Other non-operating income−22−11039−101−8−2−1
Income before tax78861081209369132143100126127138
Income tax expense192127312028363725322835
Net income from continuing operations59648190734197106759498104
Net income59648190734197106759498104
EPS, basic$0.97$1.05$1.31$1.47$1.20$0.69$1.70$1.87$1.34$1.71$1.81$1.96
EPS, diluted$0.96$1.04$1.31$1.46$1.19$0.69$1.69$1.86$1.32$1.70$1.80$1.95
Weighted average shares, basic616161616160575756555553
Weighted average shares, diluted626262616160575757555553
EBITDA140139158172146118186198160179183209
Depreciation & amortization423230313331323337333347
EBIT9910712814111386154166123145150162